We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Multiple Sclerosis

Multiple Sclerosis

Here's what we're thinking—and what we think you should know—about the future of MS.